NL8700731A - Werkwijze voor de bereiding van moranolinederivaten. - Google Patents
Werkwijze voor de bereiding van moranolinederivaten. Download PDFInfo
- Publication number
- NL8700731A NL8700731A NL8700731A NL8700731A NL8700731A NL 8700731 A NL8700731 A NL 8700731A NL 8700731 A NL8700731 A NL 8700731A NL 8700731 A NL8700731 A NL 8700731A NL 8700731 A NL8700731 A NL 8700731A
- Authority
- NL
- Netherlands
- Prior art keywords
- formula
- methanol
- compound
- present
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61087509A JPS62242692A (ja) | 1986-04-15 | 1986-04-15 | モラノリン誘導体の製造法 |
| JP8750986 | 1986-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8700731A true NL8700731A (nl) | 1987-11-02 |
Family
ID=13916951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8700731A NL8700731A (nl) | 1986-04-15 | 1987-03-30 | Werkwijze voor de bereiding van moranolinederivaten. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4806633A (sv) |
| JP (1) | JPS62242692A (sv) |
| KR (1) | KR950004899B1 (sv) |
| AT (1) | AT392474B (sv) |
| BE (1) | BE1000157A5 (sv) |
| CH (1) | CH671766A5 (sv) |
| DE (1) | DE3712799A1 (sv) |
| ES (1) | ES2005160A6 (sv) |
| FR (1) | FR2601019B1 (sv) |
| GB (1) | GB2190081B (sv) |
| IT (1) | IT1206061B (sv) |
| NL (1) | NL8700731A (sv) |
| SE (1) | SE469941B (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8069891A (en) * | 1990-06-08 | 1991-12-31 | Merrell Dow Pharmaceuticals Inc. | Novel alpha-glucosidase inhibitors |
| US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
| WO1992016640A1 (en) * | 1991-03-18 | 1992-10-01 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| CA2129140A1 (en) * | 1992-01-31 | 1993-08-05 | Akira Hasegawa | Lewis-type sugar chain derivative |
| US8579029B2 (en) * | 2008-12-31 | 2013-11-12 | Schlumberger Technology Corporation | System, method and treatment fluid for controlling fines migration |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2832268A1 (de) * | 1978-07-22 | 1980-01-31 | Bayer Ag | Pseudotrisaccharide |
| JPS602038B2 (ja) * | 1980-09-22 | 1985-01-18 | 日本新薬株式会社 | グルコシルモラノリン誘導体の製法 |
| JPS5681595A (en) * | 1979-12-08 | 1981-07-03 | Nippon Shinyaku Co Ltd | Moranoline derivative and its preparation |
| GB2064527B (en) * | 1979-12-08 | 1984-05-02 | Nippon Shinyaku Co Ltd | Moranoline derivatives and process for preparation thereof |
| JPS56108767A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Bismoranoline derivative |
| JPS56108768A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Cinnamylmoranoline derivative |
| JPS6055078B2 (ja) * | 1980-12-01 | 1985-12-03 | 日本新薬株式会社 | モラノリンの誘導体 |
| US4526784A (en) * | 1981-05-05 | 1985-07-02 | Bayer Aktiengesellschaft | Amino-cyclitol derivatives and medicaments containing them |
| JPS61115093A (ja) * | 1984-11-09 | 1986-06-02 | Nippon Shinyaku Co Ltd | モラノリン誘導体の製法 |
| US4634765A (en) * | 1984-12-18 | 1987-01-06 | Merrell Dow Pharmaceuticals Inc. | Homodisaccharide hypoglycemic agents |
-
1986
- 1986-04-15 JP JP61087509A patent/JPS62242692A/ja active Pending
-
1987
- 1987-03-30 NL NL8700731A patent/NL8700731A/nl not_active Application Discontinuation
- 1987-03-30 SE SE8701317A patent/SE469941B/sv not_active IP Right Cessation
- 1987-03-31 IT IT8747798A patent/IT1206061B/it active
- 1987-04-06 GB GB8708193A patent/GB2190081B/en not_active Expired - Fee Related
- 1987-04-13 CH CH1429/87A patent/CH671766A5/fr not_active IP Right Cessation
- 1987-04-14 FR FR878705285A patent/FR2601019B1/fr not_active Expired
- 1987-04-14 ES ES8701085A patent/ES2005160A6/es not_active Expired
- 1987-04-15 DE DE19873712799 patent/DE3712799A1/de active Granted
- 1987-04-15 US US07/039,012 patent/US4806633A/en not_active Expired - Fee Related
- 1987-04-15 BE BE8700405A patent/BE1000157A5/fr not_active IP Right Cessation
- 1987-04-15 AT AT955/87A patent/AT392474B/de not_active IP Right Cessation
- 1987-04-15 KR KR1019870003583A patent/KR950004899B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE3712799A1 (de) | 1987-10-22 |
| SE469941B (sv) | 1993-10-11 |
| CH671766A5 (sv) | 1989-09-29 |
| ES2005160A6 (es) | 1989-03-01 |
| GB2190081A (en) | 1987-11-11 |
| BE1000157A5 (fr) | 1988-06-28 |
| IT8747798A0 (it) | 1987-03-31 |
| SE8701317L (sv) | 1987-10-16 |
| SE8701317D0 (sv) | 1987-03-30 |
| KR870010070A (ko) | 1987-11-30 |
| IT1206061B (it) | 1989-04-14 |
| ATA95587A (de) | 1990-09-15 |
| JPS62242692A (ja) | 1987-10-23 |
| DE3712799C2 (sv) | 1989-04-06 |
| FR2601019A1 (fr) | 1988-01-08 |
| US4806633A (en) | 1989-02-21 |
| FR2601019B1 (fr) | 1989-05-05 |
| GB2190081B (en) | 1990-03-21 |
| AT392474B (de) | 1991-04-10 |
| GB8708193D0 (en) | 1987-05-13 |
| KR950004899B1 (ko) | 1995-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Somsák et al. | A new, scalable preparation of a glucopyranosylidene-spiro-thiohydantoin: one of the best inhibitors of glycogen phosphorylases | |
| JPH0723394B2 (ja) | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 | |
| DE3856527T2 (de) | Stereoselektives Verfahren zur Herstellung von geschützten 2',2'-difluorlactonen | |
| NL8700731A (nl) | Werkwijze voor de bereiding van moranolinederivaten. | |
| US4691012A (en) | Sialic acid derivative and process for preparing the same | |
| CA2075336A1 (en) | 3-deoxy-mannosamine derivatives and process for their preparation | |
| JPS61176598A (ja) | シチジン−ジホスフエ−ト−コリンのアシル化誘導体、その製造方法及びその治療的使用 | |
| Lerner | A simple, alternative synthesis of L-erythrose | |
| DEFERRARI et al. | Reaction of Ammonia with Some Acetylated and Benzoylated Monosaccharides. VI. Derivatives of L-Arabinose, D-Xylose, and D-Ribose | |
| US3852265A (en) | 2{40 ,3{40 -o-lower alkylidene or cyclohexylidene periplorhamnoside compounds | |
| KR920007273B1 (ko) | 프로토카테큐알데히드류의 당유도체 | |
| JP2663105B2 (ja) | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン水和物結晶及びその製造法 | |
| Falco et al. | Nucleosides. XLVIII. Synthesis of 1-(5-deoxy-. beta.-D-arabinosyl) cytosine and related compounds | |
| US3898331A (en) | 4{40 -Dehydro-oleandrin and pharmaceutical composition thereof | |
| JPS6054960B2 (ja) | 抗しゆよう性セプタシジン類似体 | |
| Greig et al. | 493. Preparation of 2-acyl derivatives of 2-amino-2-deoxy-D-glucose | |
| Aslam et al. | Chromatography Free Synthesis of Reversed N-Triazole Nucleosides Starting from α-D-Galactopyranose using 1, 3-Dipolar Cycloaddition Reactions. | |
| Nogueras et al. | Aminopyrimidines and Derivatives. 19 1. Reaction of 1, 6-Dihydro-4-Beta; D (2, 3, 4, 6-Tetra-0-Acetyl) Glucopyranosylamino-1-Methyl-Z-Methoxy-6-Oxo Pyrimidine with Choracetyl Chloride | |
| CA1280746C (en) | Method of manufacturing moranoline derivatives | |
| Richtmyer | Crystalline d-glycero-L-gluco-octulose, crystalline methyl d-glycero-α-L-gluco-octulopyranoside, and some related compounds | |
| Vorbrüggen et al. | Nucleoside Syntheses, XXI. Synthesis of 5‐Methylaminomethyl‐2‐thiouridine, a Rare Nucleoside from t‐RNA | |
| SU960187A1 (ru) | Способ получени 4(2,3,4,6-тетра-0-ацетил- @ -д-глюкопиранозил)-3-тиосемикарбазона 5-нитрофурфурола | |
| NL8700730A (nl) | Werkwijze voor de bereiding van moranolinederivaten. | |
| Davison et al. | Nitrogen-containing carbohydrate derivatives: Part XVII. Methyl 4, 6-O-benzylidene-2, 3-dideoxy-2, 3-diphenylazo-α-d-mannoside | |
| JPS634557B2 (sv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BT | A notification was added to the application dossier and made available to the public | ||
| BV | The patent application has lapsed |